Clinical Trial Update: ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating rapidly generated multivirus-specific cytotoxic T lymphocytes (CTLs) for prophylaxis and treatment of multiple viral infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Infection

Drugs mentioned

• ARMS multivirus-specific CTLs

Snippet

Sponsor: AlloVir | Conditions: Viral Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-30